Investigating the conundrum related to treatment alternatives for Gestational Diabetes Mellitus
DOI:
https://doi.org/10.33448/rsd-v13i2.45191Keywords:
Metformin; Insulin; Gestational Diabetes Mellitus.Abstract
Objective: To elucidate the doubt in question of an antidiabetic drug that has good efficacy and safety in pregnant women and that can be used as a background for patients who, due to some bias, cannot or do not want to undergo their treatment with insulin; clarify the most commonly used medications to treat GDM, both by efficacy and by the patient's wishes. Also, bring information about the disease in question. Methods: The main means of data collection is the research Google Scholar, Pubmed, Scielo, Brazilian Society of Diabetes Guideline and Febrasgo. The method of choice was evaluated based on the positive and negative points of both medications, efficacy and safety. Results and discussion: Insulin is associated with the need for high daily doses of insulin therapy, and the need for high daily doses of insulin therapy, difficulty in self-administration, stress resulting from its use, and weight gain Metformin has been shown to reduce preterm births and cesarean sections, decreased maternal obesity and with fewer results of macrosomia, jaundice and hypoglycemia. More women in the metformin group than in the insulin group said they would choose to receive their assigned treatment again. Conclusion: Metformin has been shown to be efficient in controlling blood glucose, safe for pregnant women and without evidence of teratogenicity. Insulin still remains the drug of choice because it is a molecule with a small placental passage and its Low immunogenic risk.
References
Abi-Abib, R. C. et al. (2014). Diabetes na gestação. Revista Hospital Universitário Pedro Ernesto, Rio de Janeiro, 13 (3), 40-7.
Barrett H L, Nitert M D, Jones L, O’Rourke P, Lust K, Gatford K L, et al. (2013). Determinants of maternal triglycerides in women with gestational diabetes mellitus in the Metformin in Gestational Diabetes (MiG) study. Diabetes Care. 36(7):1941-6
Barros, B .S.et al. (2021). A importância do pré-natal na prevenção de complicações maternofetais do diabetes mellitus gestacional. Revista Eletrônica Acervo Científico. Vol. 27; 1-7 DOI: https://doi.org/10.25248/REAC.e7588.2021
Barros G. M., et al. (2019). Idade como fator de risco para Diabetes Mellitus Gestacional. Cienc Cuid Saude 18(2) 3-7 DOI: 10.4025/cienccuidsaude.v18i2.45414
Brown, J. et al. (2017). Insulin for the treatment of women with gestational diabetes, Cochrane Database of Systematic Reviews, 11(3)
Di Cianne G, et al. (2007). Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: comparison with regular insulin. Diabetes Care. 30(4): e11.
Diretriz da Sociedade Brasileira de Diabetes (2023). Rastreamento e diagnóstico da hiperglicemia na gestação – Diretriz da Sociedade Brasileira de Diabetes – Ed. 2023 - DOI: 10.29327/557753.2022-11
Durnwald, C. (2020). Diabetes mellitus gestacional: controle glicêmico e prognóstico materno. https://www.uptodate.com/contents/gestational-diabetes-mellitus-glycemic-control-andmaternalprognosis?search=tratamento%20diabetes%20gestacional&source=search_result&selec tedTitle=1~150&usage_type=default&display_rank=1.
Eyal, S; Easterling, T. R; Carr, D; Umans, J. G; Miodovnik, M; Hankins, G. D. V; et al. (2010). Pharmacokinetics of Metformin during Pregnancy. Drug Metab Dispos; 38(5):833-40.
FEBRASGO (2019). Diabetes Gestacional. Revista Feminina, 47(11). P. 787
Fernandes, C. N. et al. (2020). O Diabetes Mellitus Gestacional: Causa e Tratamento. Id on Line Rev. Mult. Psic.14 (49) p. 127-139. DOI: 10.14295/idonline.v. Disponível em: http://idonline.emnuvens.com.br/id
Gui, J; Liu, Q; & Feng, L (2013). Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLoS One. 8(5): e64585.
Hedrington, M. S.; & Davis, S. N. (2017). The care of pregestational and gestational diabetes and drug metabolism considerations, Expert Opinion on Drug Metabolism & Toxicology, 13(10), p. 1029-1038.
Martins, A. M.et al. (2021) - Revista Gepesvida. 16.(7), 61-75. http://www.icepsc.com.br/ojs/index.php/gepesvida
Moreira, W (2004). Revisão de literatura e desenvolvimento científico: conceitos e estratégias para confecção. Janus, Lorena, ano 1(1), 21.
Nakabuye B, et al. (2017). Prevalence of hyperglycaemia first detected during pregnancy and subsequent obstetric outcomes at St. Francis Hospital Nsambya. BMC Research Notes, 10(174): 1-10.
Nascimento, I. B.et al. (2020). Exercício físico e metformina na obesidade gestacional e prevenção diabetes mellitus gestacional: revisão sistemática - Rev. Bras. Saúde Mater. Infant., Recife, 20 (1): 17-26 http://dx.doi.org/10.1590/1806-93042020000100002
Oliveira, C .C. G. et al. (2014). Diabetes gestacional revisada: aspectos bioquímicos e fisiopatológicos. Revista Humano Ser - Unifacex, Natal-RN, 1(1), 60-73.
Organização Pan-Americana da Saúde. Ministério da Saúde (2016). Federação Brasileira das Associações de Ginecologia e Obstetrícia. Sociedade Brasileira de Diabetes. Rastreamento e diagnóstico de diabetes mellitus gestacional no Brasil. Brasília, DF: OPAS, 2016. https://www.diabetes.org.br/profissionais/images/pdf/diabetes-gestacional-relatorio.pdf.
Pavlovic, B. M. & Carvajal, C .J. (2013). Hipoglicemiantes orales para el tratamiento de la diabetes mellitus gestacional: Revisión sistemática de la literatura, Revista chilena de obstetricia y ginecología, 78,(3), 167-178,
Pereira D. O., et al. (2017). Evaluation of prenatal consultations: prenatal access and complications in maternal-child health. Revista Ciência Plural,; 3 (3): 2-15.
Reichelt, A. J. et al. (2017). Clinical characteristics of women with gestational diabetes - comparison of two cohorts enrolled 20 years apart in southern Brazil. Sao Paulo Medical Journal, 135(4), 376-382, . FapUNIFESP (SciELO). http://dx.doi.org/10.1590/1516-3180.2016.0332190317.
Rowan, J. A; Rush, E. C; Obolonkin, V; Battin, M; Wouldes, T; & Hague, W. M. (2011). Metformin in gestational diabestes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care. 34(10):2279-84.
Silva, A. L. et al. (2017). Neonatal outcomes according to different therapies for gestational diabetes mellitus. Jornal de Pediatria, 93 (1), 87-93
Silva, J. C. et al. (2007). Glibenclamida no Tratamento do Diabete Melito Gestacional em Estudo Comparado à Insulina - Arq Bras Endocrinol Metab 51(4), 541-546
Silva, J. C, Fachin, D. R; Coral, M. L; & Bertini, A. M (2012). Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus. J Perinat Med. 2012; 40(3): 225-8.
Syngelaki A, Nicolaides K H, Balani J, Hyer S, Akolekar R, Kotecha R, Pastides A, & Shehata H (2016). Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus. N Engl J Med. 374 (1): 434-34.
Tavares, M. G. R. et al. (2019). Profile of pregnant women with gestation diabetes mellitus at increased risk for large for gestational age newborns. Rev bras ginecol. obstet; 41: 298-305.
Toledo. J. A. et al. (2017). Teoria da mente em adultos: uma revisão narrativa da literatura. Bol. Acad. Paulista de Psicologia, São Paulo, Brasil - 37(92), 141.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Luan Queiroz Fernandes Pereira; Thamires Ferreira dos Santos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
